1 Supply Summary

• 1.1 Propranolol Introduction
• 1.2 World Propranolol Supply & Forecast
  • 1.2.1 World Propranolol Production Value (2021 & 2025 & 2032)
  • 1.2.2 World Propranolol Production (2021-2032)
  • 1.2.3 World Propranolol Pricing Trends (2021-2032)
• 1.3 World Propranolol Production by Region (Based on Production Site)
  • 1.3.1 World Propranolol Production Value by Region (2021-2032)
  • 1.3.2 World Propranolol Production by Region (2021-2032)
  • 1.3.3 World Propranolol Average Price by Region (2021-2032)
  • 1.3.4 North America Propranolol Production (2021-2032)
  • 1.3.5 Europe Propranolol Production (2021-2032)
  • 1.3.6 China Propranolol Production (2021-2032)
  • 1.3.7 South America Propranolol Production (2021-2032)
  • 1.3.8 Japan Propranolol Production (2021-2032)
  • 1.3.9 India Propranolol Production (2021-2032)
• 1.4 Market Drivers, Restraints and Trends
  • 1.4.1 Propranolol Market Drivers
  • 1.4.2 Factors Affecting Demand
  • 1.4.3 Propranolol Major Market Trends

2 Demand Summary

• 2.1 World Propranolol Demand (2021-2032)
• 2.2 World Propranolol Consumption by Region
  • 2.2.1 World Propranolol Consumption by Region (2021-2026)
  • 2.2.2 World Propranolol Consumption Forecast by Region (2027-2032)
• 2.3 United States Propranolol Consumption (2021-2032)
• 2.4 China Propranolol Consumption (2021-2032)
• 2.5 Europe Propranolol Consumption (2021-2032)
• 2.6 Japan Propranolol Consumption (2021-2032)
• 2.7 South Korea Propranolol Consumption (2021-2032)
• 2.8 ASEAN Propranolol Consumption (2021-2032)
• 2.9 India Propranolol Consumption (2021-2032)

3 World Manufacturers Competitive Analysis

• 3.1 World Propranolol Production Value by Manufacturer (2021-2026)
• 3.2 World Propranolol Production by Manufacturer (2021-2026)
• 3.3 World Propranolol Average Price by Manufacturer (2021-2026)
• 3.4 Propranolol Company Evaluation Quadrant
• 3.5 Industry Rank and Concentration Rate (CR)
  • 3.5.1 Global Propranolol Industry Rank of Major Manufacturers
  • 3.5.2 Global Concentration Ratios (CR4) for Propranolol in 2025
  • 3.5.3 Global Concentration Ratios (CR8) for Propranolol in 2025
• 3.6 Propranolol Market: Overall Company Footprint Analysis
  • 3.6.1 Propranolol Market: Region Footprint
  • 3.6.2 Propranolol Market: Company Product Type Footprint
  • 3.6.3 Propranolol Market: Company Product Application Footprint
• 3.7 Competitive Environment
  • 3.7.1 Historical Structure of the Industry
  • 3.7.2 Barriers of Market Entry
  • 3.7.3 Factors of Competition
• 3.8 New Entrant and Capacity Expansion Plans
• 3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World

• 4.1 United States VS China: Propranolol Production Value Comparison
  • 4.1.1 United States VS China: Propranolol Production Value Comparison (2021 & 2025 & 2032)
  • 4.1.2 United States VS China: Propranolol Production Value Market Share Comparison (2021 & 2025 & 2032)
• 4.2 United States VS China: Propranolol Production Comparison
  • 4.2.1 United States VS China: Propranolol Production Comparison (2021 & 2025 & 2032)
  • 4.2.2 United States VS China: Propranolol Production Market Share Comparison (2021 & 2025 & 2032)
• 4.3 United States VS China: Propranolol Consumption Comparison
  • 4.3.1 United States VS China: Propranolol Consumption Comparison (2021 & 2025 & 2032)
  • 4.3.2 United States VS China: Propranolol Consumption Market Share Comparison (2021 & 2025 & 2032)
• 4.4 United States Based Propranolol Manufacturers and Market Share, 2021-2026
  • 4.4.1 United States Based Propranolol Manufacturers, Headquarters and Production Site (States, Country)
  • 4.4.2 United States Based Manufacturers Propranolol Production Value (2021-2026)
  • 4.4.3 United States Based Manufacturers Propranolol Production (2021-2026)
• 4.5 China Based Propranolol Manufacturers and Market Share
  • 4.5.1 China Based Propranolol Manufacturers, Headquarters and Production Site (Province, Country)
  • 4.5.2 China Based Manufacturers Propranolol Production Value (2021-2026)
  • 4.5.3 China Based Manufacturers Propranolol Production (2021-2026)
• 4.6 Rest of World Based Propranolol Manufacturers and Market Share, 2021-2026
  • 4.6.1 Rest of World Based Propranolol Manufacturers, Headquarters and Production Site (State, Country)
  • 4.6.2 Rest of World Based Manufacturers Propranolol Production Value (2021-2026)
  • 4.6.3 Rest of World Based Manufacturers Propranolol Production (2021-2026)

5 Market Analysis by Type

• 5.1 World Propranolol Market Size Overview by Type: 2021 VS 2025 VS 2032
• 5.2 Segment Introduction by Type
  • 5.2.1 Oral
  • 5.2.2 Injection
• 5.3 Market Segment by Type
  • 5.3.1 World Propranolol Production by Type (2021-2032)
  • 5.3.2 World Propranolol Production Value by Type (2021-2032)
  • 5.3.3 World Propranolol Average Price by Type (2021-2032)

6 Market Analysis by Application

• 6.1 World Propranolol Market Size Overview by Application: 2021 VS 2025 VS 2032
• 6.2 Segment Introduction by Application
  • 6.2.1 Arrhythmia
  • 6.2.2 Hypertension
  • 6.2.3 Others
• 6.3 Market Segment by Application
  • 6.3.1 World Propranolol Production by Application (2021-2032)
  • 6.3.2 World Propranolol Production Value by Application (2021-2032)
  • 6.3.3 World Propranolol Average Price by Application (2021-2032)

7 Company Profiles

• 7.1 Apotex
  • 7.1.1 Apotex Details
  • 7.1.2 Apotex Major Business
  • 7.1.3 Apotex Propranolol Product and Services
  • 7.1.4 Apotex Propranolol Production, Price, Value, Gross Margin and Market Share (2021-2026)
  • 7.1.5 Apotex Recent Developments/Updates
  • 7.1.6 Apotex Competitive Strengths & Weaknesses
• 7.2 Teva
  • 7.2.1 Teva Details
  • 7.2.2 Teva Major Business
  • 7.2.3 Teva Propranolol Product and Services
  • 7.2.4 Teva Propranolol Production, Price, Value, Gross Margin and Market Share (2021-2026)
  • 7.2.5 Teva Recent Developments/Updates
  • 7.2.6 Teva Competitive Strengths & Weaknesses
• 7.3 ANI Pharmaceuticals
  • 7.3.1 ANI Pharmaceuticals Details
  • 7.3.2 ANI Pharmaceuticals Major Business
  • 7.3.3 ANI Pharmaceuticals Propranolol Product and Services
  • 7.3.4 ANI Pharmaceuticals Propranolol Production, Price, Value, Gross Margin and Market Share (2021-2026)
  • 7.3.5 ANI Pharmaceuticals Recent Developments/Updates
  • 7.3.6 ANI Pharmaceuticals Competitive Strengths & Weaknesses
• 7.4 AstraZeneca
  • 7.4.1 AstraZeneca Details
  • 7.4.2 AstraZeneca Major Business
  • 7.4.3 AstraZeneca Propranolol Product and Services
  • 7.4.4 AstraZeneca Propranolol Production, Price, Value, Gross Margin and Market Share (2021-2026)
  • 7.4.5 AstraZeneca Recent Developments/Updates
  • 7.4.6 AstraZeneca Competitive Strengths & Weaknesses
• 7.5 Amneal Pharmaceuticals
  • 7.5.1 Amneal Pharmaceuticals Details
  • 7.5.2 Amneal Pharmaceuticals Major Business
  • 7.5.3 Amneal Pharmaceuticals Propranolol Product and Services
  • 7.5.4 Amneal Pharmaceuticals Propranolol Production, Price, Value, Gross Margin and Market Share (2021-2026)
  • 7.5.5 Amneal Pharmaceuticals Recent Developments/Updates
  • 7.5.6 Amneal Pharmaceuticals Competitive Strengths & Weaknesses
• 7.6 Novartis
  • 7.6.1 Novartis Details
  • 7.6.2 Novartis Major Business
  • 7.6.3 Novartis Propranolol Product and Services
  • 7.6.4 Novartis Propranolol Production, Price, Value, Gross Margin and Market Share (2021-2026)
  • 7.6.5 Novartis Recent Developments/Updates
  • 7.6.6 Novartis Competitive Strengths & Weaknesses
• 7.7 Sanofi
  • 7.7.1 Sanofi Details
  • 7.7.2 Sanofi Major Business
  • 7.7.3 Sanofi Propranolol Product and Services
  • 7.7.4 Sanofi Propranolol Production, Price, Value, Gross Margin and Market Share (2021-2026)
  • 7.7.5 Sanofi Recent Developments/Updates
  • 7.7.6 Sanofi Competitive Strengths & Weaknesses
• 7.8 Yabang Pharma
  • 7.8.1 Yabang Pharma Details
  • 7.8.2 Yabang Pharma Major Business
  • 7.8.3 Yabang Pharma Propranolol Product and Services
  • 7.8.4 Yabang Pharma Propranolol Production, Price, Value, Gross Margin and Market Share (2021-2026)
  • 7.8.5 Yabang Pharma Recent Developments/Updates
  • 7.8.6 Yabang Pharma Competitive Strengths & Weaknesses
• 7.9 Sawai Seiyaku
  • 7.9.1 Sawai Seiyaku Details
  • 7.9.2 Sawai Seiyaku Major Business
  • 7.9.3 Sawai Seiyaku Propranolol Product and Services
  • 7.9.4 Sawai Seiyaku Propranolol Production, Price, Value, Gross Margin and Market Share (2021-2026)
  • 7.9.5 Sawai Seiyaku Recent Developments/Updates
  • 7.9.6 Sawai Seiyaku Competitive Strengths & Weaknesses
• 7.10 ABZ-Pharma
  • 7.10.1 ABZ-Pharma Details
  • 7.10.2 ABZ-Pharma Major Business
  • 7.10.3 ABZ-Pharma Propranolol Product and Services
  • 7.10.4 ABZ-Pharma Propranolol Production, Price, Value, Gross Margin and Market Share (2021-2026)
  • 7.10.5 ABZ-Pharma Recent Developments/Updates
  • 7.10.6 ABZ-Pharma Competitive Strengths & Weaknesses
• 7.11 Towa Yakuhin
  • 7.11.1 Towa Yakuhin Details
  • 7.11.2 Towa Yakuhin Major Business
  • 7.11.3 Towa Yakuhin Propranolol Product and Services
  • 7.11.4 Towa Yakuhin Propranolol Production, Price, Value, Gross Margin and Market Share (2021-2026)
  • 7.11.5 Towa Yakuhin Recent Developments/Updates
  • 7.11.6 Towa Yakuhin Competitive Strengths & Weaknesses
• 7.12 Zydus Pharma
  • 7.12.1 Zydus Pharma Details
  • 7.12.2 Zydus Pharma Major Business
  • 7.12.3 Zydus Pharma Propranolol Product and Services
  • 7.12.4 Zydus Pharma Propranolol Production, Price, Value, Gross Margin and Market Share (2021-2026)
  • 7.12.5 Zydus Pharma Recent Developments/Updates
  • 7.12.6 Zydus Pharma Competitive Strengths & Weaknesses
• 7.13 Nichi-Iko Pharmaceutical
  • 7.13.1 Nichi-Iko Pharmaceutical Details
  • 7.13.2 Nichi-Iko Pharmaceutical Major Business
  • 7.13.3 Nichi-Iko Pharmaceutical Propranolol Product and Services
  • 7.13.4 Nichi-Iko Pharmaceutical Propranolol Production, Price, Value, Gross Margin and Market Share (2021-2026)
  • 7.13.5 Nichi-Iko Pharmaceutical Recent Developments/Updates
  • 7.13.6 Nichi-Iko Pharmaceutical Competitive Strengths & Weaknesses
• 7.14 Intas Pharma
  • 7.14.1 Intas Pharma Details
  • 7.14.2 Intas Pharma Major Business
  • 7.14.3 Intas Pharma Propranolol Product and Services
  • 7.14.4 Intas Pharma Propranolol Production, Price, Value, Gross Margin and Market Share (2021-2026)
  • 7.14.5 Intas Pharma Recent Developments/Updates
  • 7.14.6 Intas Pharma Competitive Strengths & Weaknesses
• 7.15 IFET
  • 7.15.1 IFET Details
  • 7.15.2 IFET Major Business
  • 7.15.3 IFET Propranolol Product and Services
  • 7.15.4 IFET Propranolol Production, Price, Value, Gross Margin and Market Share (2021-2026)
  • 7.15.5 IFET Recent Developments/Updates
  • 7.15.6 IFET Competitive Strengths & Weaknesses
• 7.16 Iqfarma
  • 7.16.1 Iqfarma Details
  • 7.16.2 Iqfarma Major Business
  • 7.16.3 Iqfarma Propranolol Product and Services
  • 7.16.4 Iqfarma Propranolol Production, Price, Value, Gross Margin and Market Share (2021-2026)
  • 7.16.5 Iqfarma Recent Developments/Updates
  • 7.16.6 Iqfarma Competitive Strengths & Weaknesses
• 7.17 Zentiva
  • 7.17.1 Zentiva Details
  • 7.17.2 Zentiva Major Business
  • 7.17.3 Zentiva Propranolol Product and Services
  • 7.17.4 Zentiva Propranolol Production, Price, Value, Gross Margin and Market Share (2021-2026)
  • 7.17.5 Zentiva Recent Developments/Updates
  • 7.17.6 Zentiva Competitive Strengths & Weaknesses

8 Industry Chain Analysis

• 8.1 Propranolol Industry Chain
• 8.2 Propranolol Upstream Analysis
  • 8.2.1 Propranolol Core Raw Materials
  • 8.2.2 Main Manufacturers of Propranolol Core Raw Materials
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis
• 8.5 Propranolol Production Mode
• 8.6 Propranolol Procurement Model
• 8.7 Propranolol Industry Sales Model and Sales Channels
  • 8.7.1 Propranolol Sales Model
  • 8.7.2 Propranolol Typical Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Methodology
• 10.2 Research Process and Data Source

The global Propranolol market size is expected to reach $ 532 million by 2032, rising at a market growth of 3.0% CAGR during the forecast period (2026-2032).
Propranolol, sold under the brand name Inderal among others, is a medication of the beta blocker class. It is used to treat high blood pressure, a number of types of irregular heart rate, thyrotoxicosis, capillary hemangiomas, performance anxiety, and essential tremors. It is used to prevent migraine headaches, and to prevent further heart problems in those with angina or previous heart attacks. It can be taken by mouth or by injection into a vein.
The global market for Propranolol is primarily driven by its broad therapeutic applications and long-standing clinical use. As a beta-blocker, Propranolol is widely prescribed for cardiovascular conditions such as hypertension, angina, and arrhythmias, all of which are on the rise globally due to aging populations, sedentary lifestyles, and poor dietary habits. Moreover, its effectiveness in managing non-cardiac conditions—such as migraine prevention, essential tremors, and anxiety disorders—significantly expands its target patient base. The affordability and availability of generic versions have made Propranolol accessible in both developed and developing regions, further contributing to market growth. Additionally, increasing awareness of mental health issues and growing off-label use for performance anxiety and PTSD have strengthened demand. Ongoing research into new indications, such as the treatment of infantile hemangiomas, also supports broader clinical adoption and market expansion.
Despite its widespread use, the Propranolol market faces several challenges that may limit its growth. One major challenge is the availability of newer, more selective beta-blockers (e.g., atenolol, bisoprolol), which are often preferred due to a more favorable side-effect profile, especially in patients with respiratory conditions. Furthermore, concerns about potential adverse effects such as bradycardia, fatigue, and hypotension may lead clinicians to opt for alternative therapies, particularly in elderly or polypharmacy patients. The off-label use of Propranolol, while contributing to market size, can also pose regulatory hurdles and medico-legal concerns. In addition, pricing pressures and intense competition among generic manufacturers reduce profit margins, discouraging innovation in formulation or delivery mechanisms. In regions with limited healthcare access, inconsistent supply chains and a lack of awareness may also restrict market penetration.
Global Propranolol key players include Apotex, Teva, Atnas Pharma, AstraZeneca, Mylan, etc. Global top five manufacturers hold a share over 28%. Europe is the largest market, with a share about 30%, followed by North America, and Asia-Pacific, both have a share about 44 percent. In terms of product, Oral is the largest segment, with a share over 98%. And in terms of application, the largest application is Arrhythmia, followed by Hypertension, and Others.
This report studies the global Propranolol production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Propranolol and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Propranolol that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Propranolol total production and demand, 2021-2032, (K Units)
Global Propranolol total production value, 2021-2032, (USD Million)
Global Propranolol production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Propranolol consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Propranolol domestic production, consumption, key domestic manufacturers and share
Global Propranolol production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Propranolol production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Propranolol production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Propranolol market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Apotex, Teva, ANI Pharmaceuticals, AstraZeneca, Amneal Pharmaceuticals, Novartis, Sanofi, Yabang Pharma, Sawai Seiyaku, ABZ-Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Propranolol market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Propranolol Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Propranolol Market, Segmentation by Type:
Oral
Injection
Global Propranolol Market, Segmentation by Application:
Arrhythmia
Hypertension
Others
Companies Profiled:
Apotex
Teva
ANI Pharmaceuticals
AstraZeneca
Amneal Pharmaceuticals
Novartis
Sanofi
Yabang Pharma
Sawai Seiyaku
ABZ-Pharma
Towa Yakuhin
Zydus Pharma
Nichi-Iko Pharmaceutical
Intas Pharma
IFET
Iqfarma
Zentiva
Key Questions Answered:
1. How big is the global Propranolol market?
2. What is the demand of the global Propranolol market?
3. What is the year over year growth of the global Propranolol market?
4. What is the production and production value of the global Propranolol market?
5. Who are the key producers in the global Propranolol market?
6. What are the growth factors driving the market demand?